What We Do
Lung Cancer Research
Lung cancer is the leading cause of cancer-related mortality in the U.S. The TREAT Lung Cancer Program is actively conducting epidemiologic and clinical research to identify predictors (genetic, clinical, and environmental) of lung cancer risk and survival. Ongoing research is conducted using multiple Vanderbilt and national resources such as the Vanderbilt Thoracic Surgery database, the Society for Thoracic Surgery Database, the Veterans Affairs Hospital, Vanderbilt BioVU, and the Southern Community Cohort Study.
Improving the accuracy of lung cancer diagnosis and prognosis
- Predictive modeling to eliminate unnecessary operations in patients with suspicious lung lesions
- Diagnostic accuracy of FDG-PET scans to diagnose lung cancer in the U.S.
- Biomarkers in lung cancer diagnosis
- Evaluation of the sub-centimeter pulmonary nodule
- Using localization techniques to evaluate suspicious lesions
- Survival of early stage lung cancer patients
- Genetic and environmental risk factors
Genetic epidemiology of pulmonary diseases and tobacco smoking
- Racial disparities in pulmonary diseases
- Racial/ethnic differences in lung cancer survival
- Gene-environment interactions
- Genetic ancestry
- Healthcare utilization and lung cancer survival
- Metformin and cancer survival
- Personalized genomic medicine
